Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.72
0.0754.57%
Last update: Dec 18, 9:41 AM
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Metagenomi (MGX) stock?
You can purchase shares of Metagenomi (NASDAQ:MGX) through any online brokerage.
Who are Metagenomi (MGX) competitors?
Other companies in Metagenomi’s space includes: InflaRx NV (NASDAQ:IFRX), Estrella Immunopharma Inc (NASDAQ:ESLA), Aligos Therapeutics Inc (NASDAQ:ALGS), OS Therapies Inc (AMEX:OSTX) and Tevogen Bio Holdings Inc (NASDAQ:TVGN).
What is the forecast, or price target, for Metagenomi (MGX) stock?
Metagenomi has a consensus price target of $11.86.
What is the current price for Metagenomi (MGX)?
The stock price for Metagenomi (NASDAQ: MGX) is $1.715 last updated December 18, 2025 at 9:41 AM EST.
Does Metagenomi (MGX) pay a dividend?
There are no upcoming dividends for Metagenomi.
When is Metagenomi (NASDAQ:MGX) reporting earnings?
Metagenomi does not have any upcoming earnings scheduled.
Is Metagenomi (MGX) going to split?
There is no upcoming split for Metagenomi.
What sector and industry does Metagenomi (MGX) operate in?
Metagenomi is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
